OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - MERCK & CO. | Market Closed - Deutsche Boerse AG 01:16:46 29/06/2024 am IST | ||
| 5.06 EUR | -4.35% |
|
| Current month | +5.20% | ||
| 1 month | +3.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 5.06 | -4.35% |
| 27/24/27 | 5.29 | -3.82% |
| 26/24/26 | 5.5 | -1.26% |
| 25/24/25 | 5.57 | 0.00% |
| 24/24/24 | 5.57 | +4.50% |
Delayed Quote Deutsche Boerse AG
Last update June 29, 2024 at 01:16 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Société Générale
|
| WKN | SB0Z0X |
| ISIN | DE000SB0Z0X7 |
| Date issued | 08/06/2020 |
| Strike | 73.02 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.54 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.67 € |
|---|---|
| Lowest since issue | 0.52 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8
USD
Average target price
142.7
USD
Spread / Average Target
+15.25%
- Stock Market
- Certificates
- Certificat
